ClinVar Miner

Variants studied for retroperitoneal cancer

Included ClinVar conditions (19):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign not provided total
403 322 1928 1170 76 12 3806

Gene and significance breakdown #

Total genes and gene combinations: 51
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign not provided total
SDHA 159 87 1246 808 53 9 2301
SDHB 167 66 511 318 20 1 1054
TP53 55 93 76 5 2 0 219
SDHAF2 4 12 42 4 1 2 63
LOC129929542, SDHB 6 1 27 26 0 0 60
PIK3CA 0 14 1 0 0 0 15
LOC129929541, SDHB 3 0 1 9 0 0 13
CTNNB1, LOC126806658 0 11 0 0 0 0 11
FBXW7 0 5 0 0 0 0 5
IDH1 0 5 0 0 0 0 5
NRAS 0 5 0 0 0 0 5
CREBBP 0 4 0 0 0 0 4
LOC129929541, LOC129929542, SDHB 2 0 2 0 0 0 4
BCOR 0 3 0 0 0 0 3
BRAF 0 3 0 0 0 0 3
GNAS 0 3 0 0 0 0 3
HRAS, LRRC56 0 3 0 0 0 0 3
SF3B1 0 3 0 0 0 0 3
ATRX 0 0 2 0 0 0 2
BAP1 0 0 2 0 0 0 2
LOC129929542, LOC129929543, SDHB 2 0 0 0 0 0 2
NOTCH1 0 2 0 0 0 0 2
ALK 0 0 1 0 0 0 1
ARID1B 0 0 1 0 0 0 1
ARID2 0 1 0 0 0 0 1
ATM 0 0 1 0 0 0 1
CDKN2C, FAF1 0 0 1 0 0 0 1
CHEK2 0 0 1 0 0 0 1
CTNNB1 0 0 1 0 0 0 1
FGFR2 0 0 1 0 0 0 1
FUS, TFCP2 0 0 1 0 0 0 1
H3-3A 0 1 0 0 0 0 1
INSL6, JAK2 0 0 1 0 0 0 1
JAK3 0 0 1 0 0 0 1
KMT2A 0 0 1 0 0 0 1
KRAS 1 0 0 0 0 0 1
LOC129929541, LOC129929542, LOC129929543, PADI2, SDHB 1 0 0 0 0 0 1
LOC129929542, LOC129929543, PADI2, SDHB 1 0 0 0 0 0 1
MECOM 0 0 1 0 0 0 1
MLH1 0 0 1 0 0 0 1
MSH6 0 0 1 0 0 0 1
MYB, NFIB 1 0 0 0 0 0 1
MYBL1, NFIB 1 0 0 0 0 0 1
RAD52 0 0 1 0 0 0 1
SDHD 1 0 0 0 0 0 1
SMARCA2 0 0 1 0 0 0 1
SMARCA4 0 0 1 0 0 0 1
SMARCB1 0 0 1 0 0 0 1
STAT3 0 0 1 0 0 0 1
STK11 0 0 1 0 0 0 1
ZMYND11 0 0 1 0 0 0 1

Submitter and significance breakdown #

Total submitters: 53
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign not provided total
Labcorp Genetics (formerly Invitae), Labcorp 311 99 1754 1144 66 0 3374
Baylor Genetics 47 41 114 0 0 0 202
Myriad Genetics, Inc. 94 41 35 9 3 0 182
Fulgent Genetics, Fulgent Genetics 22 11 67 16 2 0 118
Database of Curated Mutations (DoCM) 0 100 0 0 0 0 100
Counsyl 2 7 50 13 2 0 74
KCCC/NGS Laboratory, Kuwait Cancer Control Center 1 3 0 13 33 0 50
Genome Sciences Centre, British Columbia Cancer Agency 3 6 21 0 0 0 30
Color Diagnostics, LLC DBA Color Health 10 4 1 4 11 0 30
OMIM 21 0 0 0 0 0 21
Key Laboratory of Carcinogenesis and Cancer Invasion, Central South University 0 19 0 0 0 0 19
St. Jude Molecular Pathology, St. Jude Children's Research Hospital 2 0 11 0 0 0 13
Center for Human Genetics, Inc, Center for Human Genetics, Inc 8 1 1 0 0 0 10
MGZ Medical Genetics Center 7 1 0 0 0 0 8
GenomeConnect - Invitae Patient Insights Network 0 0 0 0 0 8 8
Department of Pediatrics, Memorial Sloan Kettering Cancer Center 6 1 0 0 0 0 7
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center 4 0 1 0 0 0 5
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine 2 3 0 0 0 0 5
Centre for Mendelian Genomics, University Medical Centre Ljubljana 3 0 2 0 0 0 5
Genome-Nilou Lab 1 0 0 0 3 0 4
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne 0 0 2 0 1 0 3
Genetics and Molecular Pathology, SA Pathology 2 1 0 0 0 0 3
Institute of Human Genetics, University of Leipzig Medical Center 1 1 1 0 0 0 3
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein 2 0 1 0 0 0 3
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia 1 0 0 0 1 0 2
GeneReviews 0 0 0 0 0 2 2
Illumina Laboratory Services, Illumina 1 1 0 0 0 0 2
Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen 0 1 1 0 0 0 2
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology 2 0 0 0 0 0 2
Institute of Human Genetics, University Hospital of Duesseldorf 0 1 1 0 0 0 2
GenomeConnect, ClinGen 0 0 0 0 0 2 2
3billion 1 0 1 0 0 0 2
Biesecker Lab/Clinical Genomics Section, National Institutes of Health 0 1 0 0 0 0 1
Genetic Services Laboratory, University of Chicago 0 1 0 0 0 0 1
Revvity Omics, Revvity 0 1 0 0 0 0 1
Mendelics 0 1 0 0 0 0 1
UCLA Clinical Genomics Center, UCLA 1 0 0 0 0 0 1
Donald Williams Parsons Laboratory, Baylor College of Medicine 0 1 0 0 0 0 1
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego 1 0 0 0 0 0 1
Clinical Genetics Laboratory, Region Ostergotland 1 0 0 0 0 0 1
Geisinger Autism and Developmental Medicine Institute, Geisinger Health System 1 0 0 0 0 0 1
Laboratory of Medical Genetics, National & Kapodistrian University of Athens 0 1 0 0 0 0 1
Johns Hopkins Genomics, Johns Hopkins University 1 0 0 0 0 0 1
University of Washington Department of Laboratory Medicine, University of Washington 0 0 0 1 0 0 1
deCODE genetics, Amgen 0 1 0 0 0 0 1
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology 0 1 0 0 0 0 1
Division of Medical Genetics, University of Washington 1 0 0 0 0 0 1
Institute of Human Genetics, University Hospital Muenster 0 1 0 0 0 0 1
New York Genome Center 0 1 0 0 0 0 1
Dr. med. U. Finckh, Human Genetics, Eurofins MVZ 0 0 1 0 0 0 1
Suma Genomics 1 0 0 0 0 0 1
Genomics England Pilot Project, Genomics England 0 1 0 0 0 0 1
Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili 0 1 0 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.